Nearmap Ltd buy krebskrebs
Start price
22.02.21
/
50%
€1.69
Target price
22.02.22
€2.50
Performance (%)
-54.14%
End price
23.02.22
€0.78
Summary
This prediction ended on 23.02.22 with a price of €0.78. Massive losses of -54.14% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nearmap Ltd | - | - | - | - |
| iShares Core DAX® | 4.642% | 7.489% | 6.987% | 53.734% |
| iShares Nasdaq 100 | 4.471% | 16.803% | 40.281% | 104.329% |
| iShares Nikkei 225® | 7.670% | 16.856% | 47.874% | 73.793% |
| iShares S&P 500 | 2.472% | 9.903% | 28.430% | 72.579% |
Comments by krebskrebs for this prediction
In the thread Nearmap Ltd diskutieren
Buy mit Kursziel 2,5
In the thread Trading Nearmap Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

